New Weight Loss Drug
May 15, 2013
New Weight Loss Drug Approvals!
RCR contributes to development process
A huge ‘thank you’ to the hundreds of RCR volunteers who have participated in weight loss studies over the last several years. There are now 2 new weight loss medications, the first ones to be FDA approved since 1999.
Qsymia (pronounced kyoo-sim-EE-uh and manufactured by Vivus Pharmaceuticals) and Belviq (pronounced bel-VEEK and manufactured by Arena Pharmaceuticals) were shown to be effective in helping people lose weight during their clinical trials.
We are grateful to our volunteers who were part of these landmark studies. For anyone interested in these medications, we recommend that you speak with your healthcare provider.
Striving for excellence
May 14, 2013
RCR LAUNCHES A “VISION EVERYDAY TEAM”
Striving for excellence . . .
Our vision is to be the best clinical research site in Rochester. We do this by providing high quality care for our study volunteers and co-workers, while providing our study sponsors with high quality data. Key to our success is maintaining a friendly, welcoming, caring and efficient office environment.
To keep us on track, our Vision Everyday Team, led by Adam Larrabee, has worked on several new initiatives:
A “Cheer for a Peer” board for staff to recognize and affirm one another’s contributions.
Participation in Wegman’s “Eat Well, Live Well Challenge”.
Promotion of healthier “standing” workstations
Office-wide “spring cleaning” and decluttering party.
Promotion of enhanced communication techniques among staff.
Development of “Referral Bonus” program for study volunteers.
Volunteer surveys to solicit feedback and to keep improving our customer service!
Your input is welcome. Anything we can do to improve your experience at RCR – please let us know!
Meningitis B Vaccine
January 29, 2013
For 10-25 year olds
When my teenagers got their meningitis vaccines, I thought they were protected against all causes of the dreaded disease. said Michael Brennan, FNP ”I was wrong.”
The currently licensed meningitis vaccines, such as Menactra®, do not provide immunity against the Meningitis B strains, which cause one-third of the cases of bacterial meningitis in the U.S.
So researchers are evaluating this new investigational Meningitis B vaccine.
Participants in this study will receive 3 shots over 6 months, and there is no blood work involved.
Call today to see if you or your child qualifies. 585-288-0890 or click here for more information and to see if you pre-qualify online.
Forgot your flu shot?
January 29, 2013
We have a flu shot study for you, which utilizes the flu strains from the approved 2012/2013 flu shot.
The study is evaluating new technologies in how flu vaccines are formulated and manufactured.
There is no placebo in this study. Everyone will get a vaccine.
Call today! If you are 50 years old or older you may qualify. Click here to find out!